BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Plemper RK. Measles Resurgence and Drug Development. Curr Opin Virol 2020;41:8-17. [PMID: 32247280 DOI: 10.1016/j.coviro.2020.02.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Siering O, Cattaneo R, Pfaller CK. C Proteins: Controllers of Orderly Paramyxovirus Replication and of the Innate Immune Response. Viruses 2022;14:137. [PMID: 35062341 DOI: 10.3390/v14010137] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hübschen JM, Gouandjika-vasilache I, Dina J. Measles. The Lancet 2022. [DOI: 10.1016/s0140-6736(21)02004-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
3 Shrestha N, Gall FM, Mathieu C, Hierweger MM, Brügger M, Alves MP, Vesin J, Banfi D, Kalbermatter D, Horvat B, Chambon M, Turcatti G, Fotiadis D, Riedl R, Plattet P. Highly Potent Host-Specific Small-Molecule Inhibitor of Paramyxovirus and Pneumovirus Replication with High Resistance Barrier. mBio 2021;:e0262121. [PMID: 34724816 DOI: 10.1128/mBio.02621-21] [Reference Citation Analysis]
4 Julander JG, Demarest JF, Taylor R, Gowen BB, Walling DM, Mathis A, Babu YS. An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral. Antiviral Res 2021;195:105180. [PMID: 34551346 DOI: 10.1016/j.antiviral.2021.105180] [Reference Citation Analysis]
5 Wittwer K, Anderson DE, Pfeffermann K, Cox RM, Wolf JD, Santibanez S, Mankertz A, Plesker R, Sticher ZM, Kolkykhalov AA, Natchus MG, Pfaller CK, Plemper RK, von Messling V. Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding. Nat Commun 2021;12:5233. [PMID: 34475387 DOI: 10.1038/s41467-021-25497-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Cox RM, Sourimant J, Govindarajan M, Natchus MG, Plemper RK. Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity. PLoS Pathog 2021;17:e1009371. [PMID: 33621266 DOI: 10.1371/journal.ppat.1009371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 de Swart RL, Takeda M. Editorial overview: Combating measles during a COVID-19 pandemic. Curr Opin Virol 2020;41:iii-vii. [PMID: 32919592 DOI: 10.1016/j.coviro.2020.08.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Du Pont V, Wirblich C, Yoon JJ, Cox RM, Schnell MJ, Plemper RK. Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor. J Virol 2020;94:e00321-20. [PMID: 32321812 DOI: 10.1128/JVI.00321-20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Aggarwal M, Plemper RK. Structural Insight into Paramyxovirus and Pneumovirus Entry Inhibition. Viruses 2020;12:E342. [PMID: 32245118 DOI: 10.3390/v12030342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]